Results
|
5241.
|
|
|
5242.
|
|
|
5243.
|
|
|
5244.
|
|
|
5245.
|
|
|
5246.
|
|
|
5247.
|
|
|
5248.
|
|
|
5249.
|
|
|
5250.
|
In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agonist for the treatment of preterm labor. [electronic resource] by
- Croci, Tiziano
- Cecchi, Roberto
- Marini, Pietro
- Rouget, Céline
- Viviani, Nunzia
- Germain, Guy
- Guagnini, Fabio
- Fradin, Yvon
- Descamps, Laurence
- Pascal, Marc
- Advenier, Charles
- Breuiller-Fouché, Michelle
- Leroy, Marie-Josèphe
- Bardou, Marc
Producer: 20070730
In:
The Journal of pharmacology and experimental therapeutics vol. 321
Availability: No items available.
|
|
5251.
|
|
|
5252.
|
|
|
5253.
|
|
|
5254.
|
|
|
5255.
|
Silencing of the Charcot-Marie-Tooth disease-associated gene GDAP1 induces abnormal mitochondrial distribution and affects Ca2+ homeostasis by reducing store-operated Ca2+ entry. [electronic resource] by
- Pla-Martín, David
- Rueda, Carlos B
- Estela, Anna
- Sánchez-Piris, Maribel
- González-Sánchez, Paloma
- Traba, Javier
- de la Fuente, Sergio
- Scorrano, Luca
- Renau-Piqueras, Jaime
- Alvarez, Javier
- Satrústegui, Jorgina
- Palau, Francesc
Producer: 20131209
In:
Neurobiology of disease vol. 55
Availability: No items available.
|
|
5256.
|
|
|
5257.
|
|
|
5258.
|
|
|
5259.
|
|
|
5260.
|
|